Search Results - "Luthi‐Carter, Ruth"
-
1
What have we learned from gene expression profiles in Huntington's disease?
Published in Neurobiology of disease (01-01-2012)“…Abstract The availability of many high-quality genome-wide expression datasets has provided an exciting and unique opportunity to better understand the…”
Get full text
Journal Article -
2
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
Published in Neurobiology of disease (01-12-2004)“…Huntington's disease (HD), an inherited neurodegenerative disorder, is caused by an abnormal polyglutamine expansion in the huntingtin protein. This genetic…”
Get full text
Journal Article -
3
MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms
Published in PloS one (17-01-2013)“…Whereas many causes and mechanisms of neurodegenerative diseases have been identified, very few therapeutic strategies have emerged in parallel. One possible…”
Get full text
Journal Article -
4
Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain
Published in Nature methods (01-11-2011)“…A computational approach for analysis of gene expression in heterogeneous samples of varying composition is presented. The authors used it to study expression…”
Get full text
Journal Article -
5
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
Published in Nature communications (27-10-2023)“…A positron emission tomography (PET) tracer detecting α-synuclein pathology will improve the diagnosis, and ultimately the treatment of α-synuclein-related…”
Get full text
Journal Article -
6
Sustained effects of nonallele-specific Huntingtin silencing
Published in Annals of neurology (01-03-2009)“…Objective Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin (htt)…”
Get full text
Journal Article -
7
Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease
Published in The Journal of clinical investigation (01-08-2011)“…Huntington disease (HD) is a devastating neurodegenerative disorder for which there are no disease-modifying treatments. Previous studies have proposed that…”
Get full text
Journal Article -
8
Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation
Published in PloS one (14-07-2011)“…The molecular phenotype of Huntington's disease (HD) is known to comprise highly reproducible changes in gene expression involving striatal signaling genes…”
Get full text
Journal Article -
9
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
Published in Nature medicine (01-01-2012)“…Huntington's disease is a neurodegenerative disease caused by the accumulation of mutant htt protein. Now, two groups led by Dimitri Krainc and Wenzhen Duan…”
Get full text
Journal Article -
10
HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration
Published in PLoS biology (01-11-2013)“…Histone deacetylase (HDAC) 4 is a transcriptional repressor that contains a glutamine-rich domain. We hypothesised that it may be involved in the molecular…”
Get full text
Journal Article -
11
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis
Published in Proceedings of the National Academy of Sciences - PNAS (27-04-2010)“…Huntington's disease (HD), an incurable neurodegenerative disorder, has a complex pathogenesis including protein aggregation and the dysregulation of neuronal…”
Get full text
Journal Article -
12
Tubulin and Tubulin Posttranslational Modifications in Alzheimer's Disease and Vascular Dementia
Published in Frontiers in aging neuroscience (29-10-2021)“…Alzheimer's disease (AD) and vascular dementia (VaD) are the two most common forms of dementia in older people. Although these two dementia types differ in…”
Get full text
Journal Article -
13
Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data
Published in BMC bioinformatics (19-04-2006)“…Gene expression microarray experiments are expensive to conduct and guidelines for acceptable quality control at intermediate steps before and after the…”
Get full text
Journal Article -
14
-
15
Location and function of TDP-43 in platelets, alterations in neurodegenerative diseases and arising considerations for current plasma biobank protocols
Published in Scientific reports (18-09-2024)“…The TAR DNA Binding Protein 43 (TDP-43) has been implicated in the pathogenesis of human neurodegenerative diseases and exhibits hallmark neuropathology in…”
Get full text
Journal Article -
16
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition
Published in The Journal of neuroscience (06-02-2013)“…We previously demonstrated that sodium butyrate is neuroprotective in Huntington's disease (HD) mice and that this therapeutic effect is associated with…”
Get full text
Journal Article -
17
Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice
Published in The Journal of neuroscience (15-10-2003)“…The precise cause of neuronal death in Huntington's disease (HD) is unknown. Although no single specific protein-protein interaction of mutant huntingtin has…”
Get full text
Journal Article -
18
Gene expression profiling of R6/2 transgenic mice with different CAG repeat lengths reveals genes associated with disease onset and progression in Huntington's disease
Published in Neurobiology of disease (01-06-2011)“…Abstract R6/2 transgenic mice with expanded CAG repeats (> 300) have a surprisingly prolonged disease progression and longer lifespan than prototypical parent…”
Get full text
Journal Article -
19
Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease
Published in PloS one (27-07-2012)“…In Huntington's disease (HD; MIM ID #143100), a fatal neurodegenerative disorder, transcriptional dysregulation is a key pathogenic feature. Histone…”
Get full text
Journal Article -
20
Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood
Published in Proceedings of the National Academy of Sciences - PNAS (04-09-2007)“…Highly quantitative biomarkers of neurodegenerative disease remain an important need in the urgent quest for disease-modifying therapies. For Huntington's…”
Get full text
Journal Article